Hangzhou Tigermed Consulting Co (FRA:5HZ1) FFO


FRA:5HZ1 Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
86 GF Score
Price €3.80
GF Value €5.04
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co FFO?

FFO (Funds from operations) only applies to REITs.

FRA:5HZ1
86GF Score
Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of €3.80 is trading 24.6% below its estimated GF Value™ of €5.04. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for FRA:5HZ1:

  • FFO:
  • GF Value™: €5.04 vs. price of €3.80 (24.6% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 03347:Hong Kong300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
86GF Score

Get the complete analysis for FRA:5HZ1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.80
Price
€5.04
GF Value